194 related articles for article (PubMed ID: 1326988)
1. Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection.
Braun L; Dürst M; Mikumo R; Crowley A; Robinson M
Mol Carcinog; 1992; 6(2):100-11. PubMed ID: 1326988
[TBL] [Abstract][Full Text] [Related]
2. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes.
Creek KE; Geslani G; Batova A; Pirisi L
Adv Exp Med Biol; 1995; 375():117-35. PubMed ID: 7645423
[TBL] [Abstract][Full Text] [Related]
3. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells.
Woodworth CD; Notario V; DiPaolo JA
J Virol; 1990 Oct; 64(10):4767-75. PubMed ID: 2168964
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes.
Ozbun MA; Meyers C
J Virol; 1996 Aug; 70(8):5437-46. PubMed ID: 8764055
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of keratin 14 gene expression after v-Ha-ras transfection of human papillomavirus-immortalized human cervical epithelial cells.
Bowden PE; Woodworth CD; Doniger J; DiPaolo JA
Cancer Res; 1992 Nov; 52(21):5865-71. PubMed ID: 1382846
[TBL] [Abstract][Full Text] [Related]
12. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression.
Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE
Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18.
Villa LL; Vieira KB; Pei XF; Schlegel R
Mol Carcinog; 1992; 6(1):5-9. PubMed ID: 1323969
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
17. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 (TGF beta 1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells.
Shier MK; Neely EB; Ward MG; Meyers C; Howett MK
Anticancer Res; 1999; 19(6B):4977-82. PubMed ID: 10697499
[TBL] [Abstract][Full Text] [Related]
20. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2000 Dec; 192(4):494-501. PubMed ID: 11113867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
